According to internal documents obtained by Bloomberg, Neuralink is gearing up to implant brain chips in 20,000 people every year by 2031. If this goes as planned, that could mean over $1 billion in annual revenue. Yep, billion with a B.
Let’s rewind a bit: Neuralink has only just started testing its brain chip in humans, and less than 10 people globally are known to have received one so far. But Elon’s vision is massive. By 2029, they expect to secure FDA approval for their first commercial brain chip called “Telepathy,” which allows people to control devices—like smartphones or computers—with just their thoughts. No hands, no voice, just brainwaves.
But that’s just the beginning.
Neuralink’s roadmap includes three types of implants:
- Telepathy: for brain-to-device communication.
- Blindsight: to help restore vision for the blind.
- Deep: targeted at treating neurological issues like tremors and Parkinson’s.
Their goal is to open five large-scale clinics by 2030 and start rolling out 10,000 surgeries per year. If each surgery costs about $50,000 (as estimated), that’s half a billion dollars in revenue from one product alone—Blindsight—which is set to launch in 2030.
But before you start imagining mind-controlled everything, remember: they’re not quite there yet. The FDA hasn’t approved any brain implant for long-term human use. And while Neuralink has seen promising early results—including patients using the chip to play games and even edit videos—the road ahead is long and heavily regulated.
Still, one thing is clear: the neurotech race is on, and Neuralink is sprinting. Whether it changes the world or not, this is one to keep your eye on.
About the Author
